CN1245623C - Lentinan molecular weight and molecular weight distribution measuring method - Google Patents
Lentinan molecular weight and molecular weight distribution measuring method Download PDFInfo
- Publication number
- CN1245623C CN1245623C CN 03112908 CN03112908A CN1245623C CN 1245623 C CN1245623 C CN 1245623C CN 03112908 CN03112908 CN 03112908 CN 03112908 A CN03112908 A CN 03112908A CN 1245623 C CN1245623 C CN 1245623C
- Authority
- CN
- China
- Prior art keywords
- molecular weight
- lentinan
- hpgpc
- determination method
- distribution determination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920001491 Lentinan Polymers 0.000 title claims abstract description 71
- 229940115286 lentinan Drugs 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims abstract description 38
- 238000004192 high performance gel permeation chromatography Methods 0.000 claims abstract description 40
- 229920002307 Dextran Polymers 0.000 claims abstract description 10
- 235000017281 sodium acetate Nutrition 0.000 claims abstract description 9
- 229920001218 Pullulan Polymers 0.000 claims abstract description 6
- 239000004373 Pullulan Substances 0.000 claims abstract description 6
- 235000019423 pullulan Nutrition 0.000 claims abstract description 6
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000012937 correction Methods 0.000 claims abstract description 4
- 150000004676 glycans Chemical class 0.000 claims abstract description 4
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 4
- 239000005017 polysaccharide Substances 0.000 claims abstract description 4
- 229910021642 ultra pure water Inorganic materials 0.000 claims abstract description 4
- 239000012498 ultrapure water Substances 0.000 claims abstract description 4
- 239000004317 sodium nitrate Substances 0.000 claims abstract description 3
- 235000010344 sodium nitrate Nutrition 0.000 claims abstract description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 10
- 238000011088 calibration curve Methods 0.000 claims description 9
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 6
- 239000001632 sodium acetate Substances 0.000 claims description 5
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 239000008366 buffered solution Substances 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- 239000008363 phosphate buffer Substances 0.000 claims description 4
- 239000007974 sodium acetate buffer Substances 0.000 claims description 3
- 239000001488 sodium phosphate Substances 0.000 claims description 3
- 239000012064 sodium phosphate buffer Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 239000010421 standard material Substances 0.000 abstract description 4
- 238000000926 separation method Methods 0.000 abstract description 3
- 229920000642 polymer Polymers 0.000 abstract description 2
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 abstract 1
- 239000008055 phosphate buffer solution Substances 0.000 abstract 1
- 229940087562 sodium acetate trihydrate Drugs 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 238000000149 argon plasma sintering Methods 0.000 description 5
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000008512 biological response Effects 0.000 description 2
- 230000000973 chemotherapeutic effect Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002356 laser light scattering Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The present invention relates to a method for measuring the molecular weight and the distribution of natural macromolecular high polymers of lentinan by a universal correction method. The method is characterized in that gel permeation chromatography-HPGPC with high efficiency is adopted; a moving phase of the HPGPC can be ultrapure water, sodium nitrate with 0.1 to 0.5M, sodium acetate trihydrate with 0.1 to 0.5M and a phosphate buffer solution; analytical columns of the HPGPC can be chromatographic columns suitable for polysaccharide, the number of the analytical columns can be from 1 to 4, and a separation range can be from 2, 000, 000 to 1000 daltons; a column temperature of the analytical columns of the HPGPC can be kept between 30 to 55 DEG C; a flow speed of the HPGPC can be from 0.1 ml/min to 1.0 ml/min; standard materials for drawing standard curves relative to the HPGPC can be Dextran or Pullulan; standard materials for drawing correction curves universally suitable for the HPGPC are graded separation products of lentinan.
Description
Technical field
The present invention relates to a kind of molecular weight and molecular weight distribution determination method, specifically a kind of lentinan molecular weight and molecular weight distribution determination method.
Background technology
Lentinan is a kind of biological response modifier (Biological Response Modifier BRM) that is widely used in anti-tumor chemotherapeutic and radiotherapy at present.Particularly be applied to the toxic and side effect that cancer of the stomach, lung cancer, intestinal cancer, breast cancer have tangible chemotherapeutic sensitivity and reduces chemotherapy and radiotherapy, the chemotherapy of other tumours is all had synergy in various degree and reduces toxic and side effect.Lentinan is to be main chain with β-D-(1 → 3) glucose, and β-D-(1 → 6) glucose is the glucosan of side chain, is the superpolymer of polydispersity.Discover that lentinan molecular weight and animal and even clinical antitumor activity have correlationship, therefore, the assay method of research lentinan molecular weight is significant to control lentinan inherent quality.Yet, the method institute accepted standard material of measuring the macromolecular polysaccharide molecular weight at present is often inequality with the chemical constitution of measured matter, what set up thus is relative standard's curve, and measured result is a relative molecular weight, with the actual molecular weight of survey material bigger error is arranged.Therefore, need set up a kind of industrial lentinan molecular weight and Determination of distribution method thereof of being fit to.
Summary of the invention
The objective of the invention is to set up the method that a kind of universal calibration method is measured lentinan natural macromolecular molecular weight of high polymer and distribution thereof.
Principle of the present invention is according to Mark-Houwink experimental formula [η=KM
α] carry out, η is an intrinsic viscosity in the formula, and M is a molecular weight, and K, α are coefficient.
One, the molecular weight of product lentinan of the present invention, molecular formula, chemical structural formula
1, molecular weight determination
Through the efficient gel permeation chromatography, adopt pervasive calibration curve method determining molecular weight mostly between 40～800,000.
2, nuclear magnetic resonance of carbon spectrum (seeing Table 1)
Table 1
| C | Lentinan (Lentinan) | Japan produces lentinan | Resolve |
| 1 | 104.6 | 104.6 | β-D-(1 → 3) glucose |
| 2 | 74.5 | 74.3 | β-D-(1 → 3) glucose |
| 3 | 87.7 | 87.7 | β-D-(1 → 3) glucose |
| 4 | 70.2 | 70.2 | β-D-(1 → 3) glucose |
| 5 | 77.8 | 77.9 | β-D-(1 → 3) glucose |
| 6 | 62.5 | 62.5 | β-D-(1 → 3) glucose |
| 1′ | 104.9 | 104.6 | β-D-(1 → 6) glucose |
| 6′ | 71.5 | 71.5 | β-D-(1 → 6) glucose |
3, infrared spectrogram (see figure 1)
4, molecular formula
The result shows through trace element analysis, and molecular formula is (C
6H
10O
5) n
5, chemical structural formula
In conjunction with spectrographic method, the primary structure formula of lentinan is as follows through chemical reactions such as periodate oxidation and Smith degradeds:
Purpose of the present invention can reach by following measure:
A kind of lentinan molecular weight and molecular weight distribution determination method is characterized in that:
Adopt efficient gel permeation chromatography-HPGPC;
The moving phase of HPGPC is selected ultrapure water, 0.1～0.5M sodium nitrate, 0.1～0.5M sodium acetate and phosphate buffered solution for use;
The analytical column of HPGPC is selected the chromatographic column that is fit to polysaccharide for use, and with one～four, separating ranges is that 2,000,000～1000 daltonian chromatographic column is formed;
The column temperature of HPGPC analytical column remains on 30 ℃～55 ℃;
The flow velocity of HPGPC is 0.1ml/min～1.0ml/min;
The standard substance of drawing HPGPC relative standard curve is with Dextran or Pullulan;
The standard substance of drawing the pervasive calibration curve of HPGPC is the fractionated product of lentinan.
Purpose of the present invention can also reach by following measure:
Adopt the typical curve of pervasive correction to measure the molecular weight and the distribution thereof of lentinan;
Adopt alkali lye dissolving lentinan;
Used alkali lye is NaOH, potassium hydroxide, sodium carbonate or sodium bicarbonate;
The concentration of used alkali lye is 0.1～1MNaOH, 0.1～1MKOH, 0.5～1MNa
2CO
3Or 0.1～1MNaHCO
3
The moving phase of HPGPC is selected sodium acetate and the phosphate buffer of 0.1mol/L for use;
The pH value of described sodium acetate and phosphate buffer is 6.0～8.0;
The array mode of the analytical column of HPGPC is three stainless steel column series connection, and separating ranges is 2,000,000～1000 dalton;
The column temperature of HPGPC analytical column is 30 ℃;
The flow velocity of HPGPC keeps 0.4ml/min;
The weight-average molecular weight dalton of lentinan fractionated product is respectively:
1、62.4×10
4，2、53.4×10
4，3、18.4×10
4，4、10.6×10
4，5、7.72×10
4；
Recording lentinan K value is 0.0535～0.0543, and the α value is 0.6～0.8;
The lentinan K value of optimizing is 0.0539, and the α value is 0.607.
The present invention adopts pervasive calibration curve that the lentinan molecular weight is proofreaied and correct the molecular weight that obtained and molecular weight distribution to similar with the light scattering method measured result, and error is less, and degree of accuracy improves.
Description of drawings
Fig. 1 is the infrared spectrogram of lentinan of the present invention;
Fig. 2 is a HPGPC detection system reappearance displayed map of the present invention.
Embodiment
Implementation step of the present invention is to adopt standard substance Pullulan series or dextran (Dextran) series that can buy on the market to measure relative standard's curve respectively, and calculating K, α value.
The present invention adopts its intrinsic viscosity of lentinan fractionated products measure further, and with the molecular weight of its fractionated product of light scattering determining, set up pervasive calibration curve, setting up with Dextran or Pullulan is general efficient gel permeation chromatography (HPGPC) the mensuration lentinan molecular weight of standard and the method for distribution thereof.
The present invention be based upon 25 batches of lentinans (trade name: Lentinan, down with) on the basis of molecular weight and molecular weight distribution (be called for short distribute, down with) experimental study gained data.Data statistic referring to table 2 K, α value.
The mensuration of lentinan K, α value:
In order to measure lentinan K, α value, choose the lentinan fractionated sample of five different molecular weights, use the light scattering determining molecular weight: 62.4 * 10
4, 53.4 * 10
4, 18.4 * 10
4, 10.6 * 10
4, 7.72 * 10
4According to the regulation of Chinese Pharmacopoeia (version in 2000) appendix, under 0.1mol/L sodium acetate and phosphate buffer (pH7.8～8.0), 30 ℃ of conditions, measure intrinsic viscosity, use η=KM
αFormula calculating K, α value have been measured 25 groups of K, α value (newly join phosphate buffer at every turn and measure the pH value, detailed numerical value sees the following form) altogether, and arithmetic mean and the standard deviation of calculating K, α are judged the choice of numerical value with the Grubbs method of inspection respectively.
The data statistic of table 2 K, α value
| Number of times | Phosphate buffer pH value | K | α |
| 1 | 7.89 | 0.0540 | 0.605 |
| 2 | 7.91 | 0.0538 | 0.607 |
| 3 | 7.93 | 0.0540 | 0.606 |
| 4 | 7.86 | 0.0538 | 0.607 |
| 5 | 7.88 | 0.0541 | 0.609 |
| 6 | 7.90 | 0.0536 | 0.604 |
| 7 | 7.84 | 0.0535 | 0.609 |
| 8 | 7.92 | 0.0537 | 0.610 |
| 9 | 7.87 | 0.0539 | 0.609 |
| 10 | 7.90 | 0.0537 | 0.609 |
| 11 | 7.91 | 0.0540 | 0.608 |
| 12 | 7.89 | 0.0537 | 0.609 |
| 13 | 7.90 | 0.0536 | 0.610 |
| 14 | 7.86 | 0.0536 | 0.608 |
| 15 | 7.94 | 0.0540 | 0.608 |
| 16 | 7.97 | 0.0542 | 0.607 |
| 17 | 7.84 | 0.0538 | 0.605 |
| 18 | 7.92 | 0.0540 | 0.605 |
| 19 | 7.90 | 0.0538 | 0.602 |
| 20 | 7.95 | 0.0540 | 0.608 |
| 21 | 7.81 | 0.0543 | 0.608 |
| 22 | 7.97 | 0.0538 | 0.607 |
| 23 | 7.87 | 0.0538 | 0.610 |
| 24 | 7.95 | 0.0537 | 0.606 |
| 25 | 7.89 | 0.0540 | 0.607 |
| Mean value | 7.90 | 0.0539 | 0.607 |
| Standard deviation | 0.0404 | 0.000200 | 0.00201 |
The present invention also adopts laser light scattering method directly to measure 6 lot number lentinan weight-average molecular weight and checks.The result shows that the data that two kinds of methods are surveyed are similar to, and error is less.
Embodiment 1 instrument: the efficient gel permeation chromatograph is U.S. Waters company workstation system, 510 pumps, 410 differential refraction detectors, Millennium2010 system software and a GPC special software.Other high performance liquid chromatograph devices with above-mentioned accessory and function also can.
Can select separating ranges when (1) chromatographic column is selected gel chromatographic columns for use for use is 2,000,000～1000 daltonian chromatographic column, can adopt three stainless steel column series connection.For example: Ultrahydrogel1000,500 and 250.
(2) moving phase is successively with ultrapure water (resistance is 18.2M), 0.1mol/L sodium acetate and phosphate buffered solution (pH=7.8, according to version Chinese Pharmacopoeia appendix preparation in 2000) be moving phase, factors such as solubleness per sample, index of refraction, appearance time and peak shape are selected phosphate buffered solution pH=7.8 for use.
HPGPC collection of illustrative plates when (3) column temperature has successively compared 30 ℃, 35 ℃, 45 ℃, 55 ℃, wherein better, better with 30 ℃ collection of illustrative plates especially with 35 ℃, 30 ℃.
(4) velocity ratio the HPGPC collection of illustrative plates when 0.2ml/min, 0.4ml/min, 0.6ml/min, 0.8ml/min, 1.0ml/min all can, but be excellent with 0.4ml/min.
(5) it is better that sample size has compared the collection of illustrative plates of HPGPC of 100 μ l, 200 μ l, 300 μ l, but with 200 μ l be excellent.
(6) the drafting selection standard material Dextran of relative standard's curve series is five, and its molecular weight is 17.5 * 10
5, 74.95 * 10
4, 41.00 * 10
4, 27.3 * 10
4, 4.86 * 10
4Or Pullulan series: 74.9 * 10
4, 38 * 10
4, 21.2 * 10
4, 10 * 10
4, 4.8 * 10
4, 2.37 * 10
4Also can.Its intrinsic viscosity at 30 ℃ of above-mentioned standard substance Dextran is respectively 74.8,57.1,48.6,35.5,23.0.According to formula η=KM
α, K, the α value of calculating standard specimen Dextran.K, α value according to Dextran are drawn relative standard's curve.
(7) drafting of pervasive calibration curve is made into the solution of 1mg/ml concentration with the Dextran standard specimen of 5 known molecular amounts and intrinsic viscosity, injects the high performance liquid chromatogram instrument, and by formula 1g η=1gK+ α 1gM calculates K and α value.The input computing machine is drawn 1g[η by GPC software] M-V
0The typical curve of (drenching volume), K value, α value input computing machine with lentinan obtain pervasive calibration curve, and the K value of lentinan and α value are narrated by following (8).(8) mensuration 1 of lentinan fractionated product and the molecular weight thereof) separation of lentinan graded product, purifying are referring to Nature 1,965 222 687-8 pages or leaves.The graded product of gained purifying is respectively with the molecular weight that light scattering method (being measured by State Bureau of Technical Supervision standard substance research centre) records five products: 62.4 * 10
4, 53.4 * 10
4, 18.4 * 10
4, 10.6 * 10
4, 7.72 * 10
4Above-mentioned fractionated product is measured its intrinsic viscosity by 38 pages of VIG three therapeutic methods of traditional Chinese medicine of Chinese Pharmacopoeia two appendix of version in 2000 respectively.2) mensuration of lentinan K, α value.According to formula η=KM
α, recording the K value of lentinan under above-mentioned moving phase system is 0.0539, the α value is 0.607.Lentinan K, α value are determined according to the data of 25 groups of measurings.Referring to table 2.
(9) lentinan HPGPC method determining molecular weight and distribution lentinan test sample 5mg thereof add the sodium hydroxide solution 0.5ml swelling of 0.5mol/L, transfer PH to 7.0～8.0 with the hydrochloric acid of 0.5mol/L again, water is settled to 5ml and shakes up, with 0.45 μ membrane filtration promptly.Draw above-mentioned lentinan need testing solution 200 μ l, inject gel permeation chrommatograph, flow velocity 0.4ml/min, record chromatogram.Promptly get lentinan molecular weight and distribution collection of illustrative plates thereof after pervasive calibration curve is proofreaied and correct.See Table 3,4.
The a collection of molecular weight cumulative weight distribution curve of table 3 lentinan (Lentinan) burst statistical form
Slice Table showing 40 of 3877 slices
| # | Cumulative％ (％) | Mol Wt (Daltons) | Retention Time (min) |
| 1 | 0.061 | 1707673 | 33.333 |
| 2 | 0.449 | 1496554 | 34.140 |
| 3 | 3.015 | 1311536 | 34.948 |
| 4 | 9.061 | 1149391 | 35.755 |
| 5 | 15.813 | 1007293 | 36.562 |
| 6 | 21.926 | 882762 | 37.370 |
| 7 | 27.394 | 773626 | 38.178 |
| 8 | 32.402 | 677983 | 38.985 |
| 9 | 37.043 | 594164 | 39.792 |
| 10 | 41.387 | 520708 | 40.600 |
| 11 | 45.514 | 456333 | 41.407 |
| 12 | 49.470 | 399917 | 42.215 |
| 13 | 53.210 | 350476 | 43.022 |
| 14 | 56.786 | 307146 | 43.830 |
| 15 | 60.219 | 269174 | 44.637 |
| 16 | 63.554 | 235896 | 45.445 |
| 17 | 66.759 | 206732 | 46.252 |
| 18 | 69.813 | 181174 | 47.060 |
| 19 | 72.661 | 158776 | 47.867 |
| 20 | 75.277 | 139146 | 48.675 |
| 21 | 77.721 | 121944 | 49.482 |
| 22 | 79.946 | 106868 | 50.290 |
| 23 | 82.033 | 93656 | 51.097 |
| 24 | 83.981 | 82077 | 51.905 |
| 25 | 85.793 | 71930 | 52.712 |
| 26 | 87.524 | 63037 | 53.520 |
| 27 | 89.191 | 55244 | 54.327 |
| 28 | 90.757 | 48414 | 55.135 |
| 29 | 92.273 | 42429 | 55.942 |
| 30 | 93.713 | 37183 | 56.750 |
| 31 | 94.999 | 32586 | 57.557 |
| 32 | 96.067 | 28558 | 58.365 |
| 33 | 96.971 | 25027 | 59.172 |
| 34 | 97.721 | 21933 | 59.980 |
| 35 | 98.338 | 19222 | 60.787 |
| 36 | 98.839 | 16845 | 61.595 |
| 37 | 99.277 | 14763 | 62.402 |
| 38 | 99.624 | 12938 | 63.210 |
| 39 | 99.875 | 11338 | 64.017 |
| 40 | 100.000 | 9936 | 64.825 |
(10) reliability of pervasive calibration curve and evaluation of the accuracy see Table 4.
Table 4 HPGPC method and laser light scattering method are measured lentinan molecular weight comparison sheet as a result
| The raw material lot number | Weight-average molecular weight (Mw) (unit: ten thousand) | Relative deviation (%) | |
| The HPGPC method | Light scattering method | ||
| 1 | 60.0 | 57.5 | 2.1 |
| 2 | 50.2 | 53.0 | 2.7 |
| 3 | 70.4 | 71.8 | 1.0 |
| 4 | 56.6 | 61.0 | 3.7 |
| 5 | 57.7 | 59.7 | 1.7 |
| 6 | 54.9 | 52.2 | 2.5 |
(11) HPGPC detection system reappearance is investigated to investigating the reappearance of HPGPC system, and a collection of lentinan for injection (Lentinan) is repeated sample introduction 5 times, and it the results are shown in Figure 2 and table 5.
The HPGPC collection of illustrative plates parameter that the repetition of certain batch of table 5 lentinan for injection is 5 times relatively
(12) data processing adopts Millennium2010 system software and the GPC special software that Waters company provides, and above software all obtains the U.S. FDA approval.
Claims (13)
1, a kind of lentinan molecular weight and molecular weight distribution determination method is characterized in that:
Adopt efficient gel permeation chromatography-HPGPC;
The moving phase of HPGPC is selected ultrapure water, 0.1～0.5M sodium nitrate, 0.1～0.5M sodium acetate and phosphate buffered solution for use;
The analytical column of HPGPC is selected the chromatographic column that is fit to polysaccharide for use, and with one～four, separating ranges is that 2,000,000～1000 daltonian chromatographic column is formed;
The column temperature of HPGPC analytical column remains on 30 ℃～55 ℃;
The flow velocity of HPGPC is 0.1ml/min～1.0ml/min;
The standard substance of drawing HPGPC relative standard curve is with Dextran or Pullulan;
The standard substance of drawing the pervasive calibration curve of HPGPC is the fractionated product of lentinan.
2, lentinan molecular weight according to claim 1 and molecular weight distribution determination method is characterized in that adopting the typical curve of pervasive correction to measure the molecular weight and the distribution thereof of lentinan.
3, lentinan molecular weight according to claim 2 and molecular weight distribution determination method is characterized in that adopting alkali lye dissolving lentinan.
4, lentinan molecular weight according to claim 3 and molecular weight distribution determination method is characterized in that used alkali lye is NaOH, potassium hydroxide, sodium carbonate or sodium bicarbonate.
5, lentinan molecular weight according to claim 4 and molecular weight distribution determination method, the concentration that it is characterized in that used alkali lye is 0.1～1MNaOH, 0.1～1MKOH, 0.5MNa
2CO
3Or 0.1～1MNaHCO
3
6, lentinan molecular weight according to claim 1 and molecular weight distribution determination method, the moving phase that it is characterized in that HPGPC is selected sodium acetate and the phosphate buffer of 0.1mol/L for use.
7, lentinan molecular weight according to claim 6 and molecular weight distribution determination method, the pH that it is characterized in that described sodium acetate and phosphate buffer is 6.0～8.0.
8, lentinan molecular weight according to claim 1 and molecular weight distribution determination method, the array mode that it is characterized in that the analytical column of HPGPC are three stainless steel column series connection, and separating ranges is 2,000,000～1000 dalton.
9, lentinan molecular weight according to claim 1 and molecular weight distribution determination method, the column temperature that it is characterized in that the HPGPC analytical column is 30 ℃.
10, lentinan molecular weight according to claim 1 and molecular weight distribution determination method is characterized in that the flow velocity of HPGPC keeps 0.4ml/min.
11, lentinan molecular weight according to claim 1 and molecular weight distribution determination method, its principle system is according to Mark-Houwink experimental formula [η=KM
α] carry out, η is an intrinsic viscosity in the formula, and M is a molecular weight, and K, α are coefficient, it is characterized in that the weight-average molecular weight dalton of the fractionated product of lentinan is respectively:
1、62.4×10
4，2、53.4×10
4，3、18.4×10
4，4、10.6×10
4，5、7.72×10
4。
12, lentinan molecular weight according to claim 11 and molecular weight distribution determination method, it is characterized in that adopting lentinan fractionated product to record lentinan K value is 0.0535～0.0543, the α value is 0.6～0.8.
13, lentinan molecular weight according to claim 11 and molecular weight distribution determination method is characterized in that lentinan K value is 0.0539, and the α value is 0.607.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03112908 CN1245623C (en) | 2003-03-04 | 2003-03-04 | Lentinan molecular weight and molecular weight distribution measuring method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03112908 CN1245623C (en) | 2003-03-04 | 2003-03-04 | Lentinan molecular weight and molecular weight distribution measuring method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1437019A CN1437019A (en) | 2003-08-20 |
| CN1245623C true CN1245623C (en) | 2006-03-15 |
Family
ID=27634169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03112908 Expired - Lifetime CN1245623C (en) | 2003-03-04 | 2003-03-04 | Lentinan molecular weight and molecular weight distribution measuring method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1245623C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7650152B2 (en) | 2000-12-15 | 2010-01-19 | Adaptix, Inc. | Multi-carrier communications with adaptive cluster configuration and switching |
| US7933244B2 (en) | 2000-12-15 | 2011-04-26 | Adaptix, Inc. | Multi-carrier communications with group-based subcarrier allocation |
| US8760992B2 (en) | 2004-12-07 | 2014-06-24 | Adaptix, Inc. | Method and system for switching antenna and channel assignments in broadband wireless networks |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2640767T3 (en) * | 2004-08-12 | 2017-11-06 | Lipoxen Technologies Limited | Fractionation of loaded polysaccharides |
| CN101059483B (en) * | 2007-05-25 | 2010-11-24 | 南京生命能科技开发有限公司 | Method for Determination of Molecular Weight and Molecular Weight Distribution of Sugar-iron Hydroxide Complex |
| CN101441202B (en) * | 2008-12-29 | 2011-08-10 | 河南工业大学 | Method for detecting fungal polysaccharide |
| CN101852782B (en) * | 2009-04-02 | 2011-11-30 | 鲁南制药集团股份有限公司 | Method for measuring impurity content of faropenem polymers in faropenem sodium raw materials and preparations |
| US8195405B2 (en) * | 2009-06-30 | 2012-06-05 | Wyatt Technology Corporation | Method for characterizing reversible association of macromolecules at high concentration |
| CN102262067A (en) * | 2010-05-31 | 2011-11-30 | 北京化工大学 | Attenuate total reflection infrared spectrometry for fast detection of iodine value of edible oil |
| CN108152513B (en) * | 2011-09-29 | 2020-07-24 | 西雅图基因公司 | Overall molecular weight determination of protein-coupled reagent compounds |
| CN102590408B (en) * | 2012-01-04 | 2014-07-09 | 亚宝药业集团股份有限公司 | Method for detecting macromolecular substances in perhexiline injection |
| CN103954716A (en) * | 2014-04-24 | 2014-07-30 | 上海慈瑞医药科技有限公司 | Method for measuring molecular weight and molecular weight distribution of lentinan |
| CN105203482B (en) * | 2015-09-23 | 2018-08-07 | 西南石油大学 | The assay method of hydrophobic associated polymer molecular weight distribution curve |
| CN106198594B (en) * | 2016-06-20 | 2018-07-27 | 中国科学院长春应用化学研究所 | A kind of characterizing method of polymer molecular weight |
| CN109459523B (en) | 2017-09-06 | 2022-11-08 | 上海绿谷制药有限公司 | A kind of method for measuring the weight-average molecular weight and content of acid sugar soluble salt |
| CN109459505B (en) * | 2017-09-06 | 2023-04-25 | 绿谷(上海)医药科技有限公司 | Method for measuring weight average molecular weight and content of mannuronic acid substances |
| CN109682893A (en) * | 2017-10-19 | 2019-04-26 | 上海慈瑞通鑫医药技术有限公司 | The measuring method of lentinan content in lentinan composition |
| CN109682903A (en) * | 2019-02-19 | 2019-04-26 | 天津赛诺制药有限公司 | A kind of detection method of astragalus root polysaccharide molecular weight |
| CN113281443A (en) * | 2021-06-07 | 2021-08-20 | 广州广电计量检测股份有限公司 | Polysaccharide detection method |
-
2003
- 2003-03-04 CN CN 03112908 patent/CN1245623C/en not_active Expired - Lifetime
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8964719B2 (en) | 2000-12-15 | 2015-02-24 | Adaptix, Inc. | OFDMA with adaptive subcarrier-cluster configuration and selective loading |
| US8891414B2 (en) | 2000-12-15 | 2014-11-18 | Adaptix, Inc. | Multi-carrier communications with adaptive cluster configuration and switching |
| US7933244B2 (en) | 2000-12-15 | 2011-04-26 | Adaptix, Inc. | Multi-carrier communications with group-based subcarrier allocation |
| US8036199B2 (en) | 2000-12-15 | 2011-10-11 | Adaptix, Inc. | OFDMA with adaptive subcarrier-cluster configuration and selective loading |
| US8738020B2 (en) | 2000-12-15 | 2014-05-27 | Adaptix, Inc. | Multi-carrier communications with adaptive cluster configuration and switching |
| US8743729B2 (en) | 2000-12-15 | 2014-06-03 | Adaptix, Inc. | Multi-carrier communications with adaptive cluster configuration and switching |
| US8743717B2 (en) | 2000-12-15 | 2014-06-03 | Adaptix, Inc. | Multi-carrier communications with adaptive cluster configuration and switching |
| US8750238B2 (en) | 2000-12-15 | 2014-06-10 | Adaptix, Inc. | Multi-carrier communications with adaptive cluster configuration and switching |
| US9344211B2 (en) | 2000-12-15 | 2016-05-17 | Adaptix, Inc. | OFDMA with adaptive subcarrier-cluster configuration and selective loading |
| US8767702B2 (en) | 2000-12-15 | 2014-07-01 | Adaptix, Inc. | Multi-carrier communications with adaptive cluster configuration and switching |
| US7715358B2 (en) | 2000-12-15 | 2010-05-11 | Adaptix, Inc. | OFDMA with adaptive subcarrier-cluster configuration and selective loading |
| US8934445B2 (en) | 2000-12-15 | 2015-01-13 | Adaptix, Inc. | Multi-carrier communications with adaptive cluster configuration and switching |
| US9219572B2 (en) | 2000-12-15 | 2015-12-22 | Adaptix, Inc. | OFDMA with adaptive subcarrier-cluster configuration and selective loading |
| US8934375B2 (en) | 2000-12-15 | 2015-01-13 | Adaptix, Inc. | OFDMA with adaptive subcarrier-cluster configuration and selective loading |
| US8958386B2 (en) | 2000-12-15 | 2015-02-17 | Adaptix, Inc. | Multi-carrier communications with adaptive cluster configuration and switching |
| US7650152B2 (en) | 2000-12-15 | 2010-01-19 | Adaptix, Inc. | Multi-carrier communications with adaptive cluster configuration and switching |
| US9191138B2 (en) | 2000-12-15 | 2015-11-17 | Adaptix, Inc. | OFDMA with adaptive subcarrier-cluster configuration and selective loading |
| US9203553B1 (en) | 2000-12-15 | 2015-12-01 | Adaptix, Inc. | OFDMA with adaptive subcarrier-cluster configuration and selective loading |
| US9210708B1 (en) | 2000-12-15 | 2015-12-08 | Adaptix, Inc. | OFDMA with adaptive subcarrier-cluster configuration and selective loading |
| US8797970B2 (en) | 2004-12-07 | 2014-08-05 | Adaptix, Inc. | Method and system for switching antenna and channel assignments in broadband wireless networks |
| US8760992B2 (en) | 2004-12-07 | 2014-06-24 | Adaptix, Inc. | Method and system for switching antenna and channel assignments in broadband wireless networks |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1437019A (en) | 2003-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1245623C (en) | Lentinan molecular weight and molecular weight distribution measuring method | |
| Restaino et al. | A multi-analytical approach to better assess the keratan sulfate contamination in animal origin chondroitin sulfate | |
| Drzeżdżon et al. | MALDI-MS for polymer characterization–recent developments and future prospects | |
| Bisio et al. | Determination of the molecular weight of low-molecular-weight heparins by using high-pressure size exclusion chromatography on line with a triple detector array and conventional methods | |
| CN101493446A (en) | Method for measuring free polyethyleneglycol content in sample or products | |
| CN109682901A (en) | The average degree of modification measuring method of Pegylation protein medicaments | |
| CN102190739A (en) | Process for extracting lentinan and method for measuring molecular weight distribution of lentinan | |
| Mourey | SEC molecular-weight-sensitive detection | |
| CN106940348A (en) | It is a kind of to determine carboxyl maltose iron molecule amount and its method for distribution | |
| CN111272895A (en) | A method for simultaneous rapid detection of amino sugar, neutral sugar and uronic acid in seaweed | |
| Costa et al. | Endotoxin contamination of nanoparticle formulations: a concern in vaccine adjuvant mechanistic studies | |
| CN101059483A (en) | Sugar-ferric hydroxide composite molecular weight and molecular weight distribution determination method | |
| CN109580428A (en) | A kind of method of hyaluronan molecule amount in simplicity Accurate Determining solution | |
| CN103954716A (en) | Method for measuring molecular weight and molecular weight distribution of lentinan | |
| CN111289666A (en) | Construction method of lentinan multivariate quantitative fingerprint spectrum | |
| CN1693890A (en) | GC/MS inner scaling detection method for simultaneous investigating residual multiple organophosphorus in food | |
| CN1271403C (en) | Polysaccharide quantitative detecting method and system | |
| CN1945313A (en) | Method for detecting lentinan molecular weight and molecular weight distribution | |
| Zhang et al. | Effect of molecular mass on antitumor activity of heteropolysaccharide from Poria cocos | |
| CN1217191C (en) | Homologous system model method for quantitatively detecting bacterial endotoxin of blood | |
| CN1880344A (en) | Low molecular weight heparin and its preparation method | |
| CN114252516A (en) | Method for detecting polymer in cefuroxime sodium | |
| CN102243215A (en) | Detection method for water-soluble glucomannan | |
| CN1776423A (en) | Ganoderma spore polysaccharide molecular weight and its distribution measuring method | |
| CN112986457A (en) | Method for detecting polysaccharide by HPSEC-MALS method and correlating polysaccharide with Sepharose CL-4B method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: NANJING KANGHAI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: NANJING ZHENZHONG BIOLOGICAL ENGINEERING CO., LTD. Effective date: 20040625 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20040625 Address after: 210061 hi tech Industrial Development Zone, Jiangsu, Nanjing Applicant after: Kanghai Pharmaceutical Co.,Ltd. Nanjing Address before: 210061 hi tech Industrial Development Zone, Jiangsu, Nanjing Applicant before: Nanjing Zhenzhong Bioengineering Co.,Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NANJING SIKE PHARMA CO., LTD. Free format text: FORMER OWNER: NANJING KANGHAI PHARMACEUTICAL CO., LTD. Effective date: 20101213 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C56 | Change in the name or address of the patentee |
Owner name: NANJING LVYE SIKE PHARMA CO., LTD. Free format text: FORMER NAME: NANJING SIKE PHARMA CO., LTD. |
|
| CP03 | Change of name, title or address |
Address after: High road 210061 Jiangsu city of Nanjing province high tech Industrial Development Zone No. 28 Patentee after: NANJING LVYE PHARMACEUTICAL CO.,LTD. Address before: 210061 hi tech Industrial Development Zone, Jiangsu, Nanjing Patentee before: Nanjing Cike Pharmaceutical Co.,Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20101213 Address after: 210061 hi tech Industrial Development Zone, Jiangsu, Nanjing Patentee after: Nanjing Cike Pharmaceutical Co.,Ltd. Address before: 210061 hi tech Industrial Development Zone, Jiangsu, Nanjing Patentee before: Kanghai Pharmaceutical Co.,Ltd. Nanjing |
|
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Kanghai Pharmaceutical Co.,Ltd. Nanjing Assignor: NANJING LVYE PHARMACEUTICAL CO.,LTD. Contract record no.: 2010320001161 Denomination of invention: Lentinan molecular weight and molecular weight distribution measuring method Granted publication date: 20060315 License type: Exclusive License Open date: 20030820 Record date: 20101028 |
|
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: NANJING LVYE PHARMACEUTICAL CO.,LTD. Assignor: Kanghai Pharmaceutical Co.,Ltd. Nanjing Contract record no.: 2010320001161 Denomination of invention: Lentinan molecular weight and molecular weight distribution measuring method Granted publication date: 20060315 License type: Exclusive License Open date: 20030820 Record date: 20101028 |
|
| C56 | Change in the name or address of the patentee | ||
| CP01 | Change in the name or title of a patent holder |
Address after: High road 210061 Jiangsu city of Nanjing province high tech Industrial Development Zone No. 28 Patentee after: NANJING LUYE PHARMACEUTICAL Co.,Ltd. Address before: High road 210061 Jiangsu city of Nanjing province high tech Industrial Development Zone No. 28 Patentee before: NANJING LVYE PHARMACEUTICAL CO.,LTD. |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20060315 |